What are you looking for today?

Gartlon, J, Szekeres, P, Pullen, M, Sarau, HM, Aiyar, N, Shabon, U, Michalovich, D, Steplewski, K, Ellis, C, Elshourbagy, N, Duxon, M, Ashmeade, TE, Harrison, DC, Murdock, P, Wilson, S, Ennaceur, Abdelkader, Atkins, A, Heidbreder, C, Hagan, JJ, Hunter, AJ and Jones, DNC (2004) Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology, 177. pp. 1-14. ISSN 0033-3158

Document

  • [thumbnail of Neuromedin U]
    Neuromedin U
    Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.pdf - Published Version

Abstract

Abstract

Rationale: Neuromedin-U (NmU) is an agonist at NMU1R and NMU2R. The brain distribution of NmU and its receptors, in particular NMU2R, suggests widespread central roles for NmU. In agreement, centrally administered NmU affects feeding behaviour, energy expenditure and pituitary output. Further central nervous system (CNS) roles for NmU warrant investigation.

Objectives: To investigate the CNS role of NmU by mapping NMU1R and NMU2R mRNA and measuring the behavioural, endocrine, neurochemical and c-fos response to intracerebroventricular (i.c.v.) NmU. Methods: Binding affinity and functional potency of rat NmU was determined at human NMU1R and NMU2R. Expression of NMU1R and NMU2R mRNA in rat and human tissue was determined using semi-quantitative reverse-transcription polymerase chain reaction. In in-vivo studies, NmU was administered i.c.v. to male Sprague-Dawley rats, and changes in grooming, motor activity and pre-pulse inhibition (PPI) were assessed. In further studies, plasma endocrine hormones, [DOPAC + HVA]/[dopamine] and [5-HIAA]/[5-HT] ratios and levels of Fos-like immunoreactivity (FLI) were measured 20 min post-NmU (i.c.v.).

Results: NmU bound to NMU1R (KI, 0.11±0.02 nM) and NMU2R (KI, 0.21±0.05 nM) with equal affinity and was equally active at NMU1R (EC50, 1.25±0.05 nM) and NMU2R (EC50, 1.10±0.20 nM) in a functional assay. NMU2R mRNA expression was found at the highest levels in the CNS regions of both rat and human tissues. NMU1R mRNA expression was restricted to the periphery of both species with the exception of the rat amygdala. NmU caused a marked increase in grooming and motor activity but did not affect PPI. Further, NmU decreased plasma prolactin but did not affect levels of corticosterone, luteinising hormone or thyroid stimulating hormone. NmU elevated levels of 5-HT in the frontal cortex and hypothalamus, with decreased levels of its metabolites in the hippocampus and hypothalamus, but did not affect dopamine function. NmU markedly increased FLI in the nucleus accumbens, frontal cortex and central amygdala.

Conclusions: These data provide further evidence for widespread roles for NmU and its receptors in the brain.

Item Type: Article
Related URLs:
Depositing User: Abdelkader Ennaceur
URI: https://sure.sunderland.ac.uk/id/eprint/5958

Further Details

More Information

Related URLs
Depositing User

Identifiers

Item ID
5958
Identification Number
ISSN
0033-3158

Users with ORCIDS

ORCID for Abdelkader Ennaceur

Catalogue record

Date Deposited
08 Feb 2016 11:57
Last Modified
26 Nov 2025 09:09

Contributors

Author
J Gartlon
Author
P Szekeres
Author
M Pullen
Author
HM Sarau
Author
N Aiyar
Author
U Shabon
Author
D Michalovich
Author
K Steplewski
Author
C Ellis
Author
N Elshourbagy
Author
M Duxon
Author
TE Ashmeade
Author
DC Harrison
Author
P Murdock
Author
S Wilson
Author
A Atkins
Author
C Heidbreder
Author
JJ Hagan
Author
AJ Hunter
Author
DNC Jones

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year